Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Genome-wide association study identifies multiple risk loci for renal cell carcinoma.

Ghislaine Scelo | Mark P Purdue | Kevin M Brown | Mattias Johansson | Zhaoming Wang | Jeanette E Eckel-Passow | Yuanqing Ye | Jonathan N Hofmann | Jiyeon Choi | Matthieu Foll | Valerie Gaborieau | Mitchell J Machiela | Leandro M Colli | Peng Li | Joshua N Sampson | Behnoush Abedi-Ardekani | Celine Besse | Helene Blanche | Anne Boland | Laurie Burdette | Amelie Chabrier | Geoffroy Durand | Florence Le Calvez-Kelm | Egor Prokhortchouk | Nivonirina Robinot | Konstantin G Skryabin | Magdalena B Wozniak | Meredith Yeager | Gordana Basta-Jovanovic | Zoran Dzamic | Lenka Foretova | Ivana Holcatova | Vladimir Janout | Dana Mates | Anush Mukeriya | Stefan Rascu | David Zaridze | Vladimir Bencko | Cezary Cybulski | Eleonora Fabianova | Viorel Jinga | Jolanta Lissowska | Jan Lubinski | Marie Navratilova | Peter Rudnai | Neonila Szeszenia-Dabrowska | Simone Benhamou | Geraldine Cancel-Tassin | Olivier Cussenot | Laura Baglietto | Heiner Boeing | Kay-Tee Khaw | Elisabete Weiderpass | Borje Ljungberg | Raviprakash T Sitaram | Fiona Bruinsma | Susan J Jordan | Gianluca Severi | Ingrid Winship | Kristian Hveem | Lars J Vatten | Tony Fletcher | Kvetoslava Koppova | Susanna C Larsson | Alicja Wolk | Rosamonde E Banks | Peter J Selby | Douglas F Easton | Paul Pharoah | Gabriella Andreotti | Laura E Beane Freeman | Stella Koutros | Demetrius Albanes | Satu Männistö | Stephanie Weinstein | Peter E Clark | Todd L Edwards | Loren Lipworth | Susan M Gapstur | Victoria L Stevens | Hallie Carol | Matthew L Freedman | Mark M Pomerantz | Eunyoung Cho | Peter Kraft | Mark A Preston | Kathryn M Wilson | J Michael Gaziano | Howard D Sesso | Amanda Black | Neal D Freedman | Wen-Yi Huang | John G Anema | Richard J Kahnoski | Brian R Lane | Sabrina L Noyes | David Petillo | Bin Tean Teh | Ulrike Peters | Emily White | Garnet L Anderson | Lisa Johnson | Juhua Luo | Julie Buring | I-Min Lee | Wong-Ho Chow | Lee E Moore | Christopher Wood | Timothy Eisen | Marc Henrion | James Larkin | Poulami Barman | Bradley C Leibovich | Toni K Choueiri | G Mark Lathrop | Nathaniel Rothman | Jean-Francois Deleuze | James D McKay | Alexander S Parker | Xifeng Wu | Richard S Houlston | Paul Brennan | Stephen J Chanock
Nature communications | 2017

Previous genome-wide association studies (GWAS) have identified six risk loci for renal cell carcinoma (RCC). We conducted a meta-analysis of two new scans of 5,198 cases and 7,331 controls together with four existing scans, totalling 10,784 cases and 20,406 controls of European ancestry. Twenty-four loci were tested in an additional 3,182 cases and 6,301 controls. We confirm the six known RCC risk loci and identify seven new loci at 1p32.3 (rs4381241, P=3.1 × 10-10), 3p22.1 (rs67311347, P=2.5 × 10-8), 3q26.2 (rs10936602, P=8.8 × 10-9), 8p21.3 (rs2241261, P=5.8 × 10-9), 10q24.33-q25.1 (rs11813268, P=3.9 × 10-8), 11q22.3 (rs74911261, P=2.1 × 10-10) and 14q24.2 (rs4903064, P=2.2 × 10-24). Expression quantitative trait analyses suggest plausible candidate genes at these regions that may contribute to RCC susceptibility.

Pubmed ID: 28598434 RIS Download

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: Medical Research Council, United Kingdom
    Id: MR/N003284/1
  • Agency: NCI NIH HHS, United States
    Id: U01 CA155309
  • Agency: Medical Research Council, United Kingdom
    Id: G1000143
  • Agency: Cancer Research UK, United Kingdom
    Id: 14136
  • Agency: Medical Research Council, United Kingdom
    Id: G0401527
  • Agency: Cancer Research UK, United Kingdom
    Id: 6858
  • Agency: Department of Health, United Kingdom
    Id: RP-PG-0707-10101
  • Agency: Cancer Research UK, United Kingdom
    Id: 10124

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


University of Texas MD Anderson Cancer Center (tool)

RRID:SCR_004699

The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public. VISION: We shall be the premier cancer center in the world, based on the excellence of our people, our research-driven patient care and our science. We are Making Cancer History.

View all literature mentions

International Agency for Research on Cancer (tool)

RRID:SCR_005422

The International Agency for Research on Cancer (IARC) is part of the World Health Organization. IARC''s mission is to coordinate and conduct research on the causes of human cancer, the mechanisms of carcinogenesis, and to develop scientific strategies for cancer prevention and control. The Agency is involved in both epidemiological and laboratory research and disseminates scientific information through publications, meetings, courses, and fellowships.

View all literature mentions

1000 Genomes Project and AWS (tool)

RRID:SCR_008801

A dataset containing the full genomic sequence of 1,700 individuals, freely available for research use. The 1000 Genomes Project is an international research effort coordinated by a consortium of 75 companies and organizations to establish the most detailed catalogue of human genetic variation. The project has grown to 200 terabytes of genomic data including DNA sequenced from more than 1,700 individuals that researchers can now access on AWS for use in disease research free of charge. The dataset containing the full genomic sequence of 1,700 individuals is now available to all via Amazon S3. The data can be found at: http://s3.amazonaws.com/1000genomes The 1000 Genomes Project aims to include the genomes of more than 2,662 individuals from 26 populations around the world, and the NIH will continue to add the remaining genome samples to the data collection this year. Public Data Sets on AWS provide a centralized repository of public data hosted on Amazon Simple Storage Service (Amazon S3). The data can be seamlessly accessed from AWS services such Amazon Elastic Compute Cloud (Amazon EC2) and Amazon Elastic MapReduce (Amazon EMR), which provide organizations with the highly scalable compute resources needed to take advantage of these large data collections. AWS is storing the public data sets at no charge to the community. Researchers pay only for the additional AWS resources they need for further processing or analysis of the data. All 200 TB of the latest 1000 Genomes Project data is available in a publicly available Amazon S3 bucket. You can access the data via simple HTTP requests, or take advantage of the AWS SDKs in languages such as Ruby, Java, Python, .NET and PHP. Researchers can use the Amazon EC2 utility computing service to dive into this data without the usual capital investment required to work with data at this scale. AWS also provides a number of orchestration and automation services to help teams make their research available to others to remix and reuse. Making the data available via a bucket in Amazon S3 also means that customers can crunch the information using Hadoop via Amazon Elastic MapReduce, and take advantage of the growing collection of tools for running bioinformatics job flows, such as CloudBurst and Crossbow.

View all literature mentions

SNPTEST (tool)

RRID:SCR_009406

Software program for the analysis of single SNP association in genome-wide studies. The tests implemented can cater for binary (case-control) and quantitative phenotypes, can condition upon an arbitrary set of covariates and properly account for the uncertainty in genotypes. The program is designed to work seamlessly with the output of both the genotype calling program CHIAMO, the genotype imputation program IMPUTE and the program GTOOL. This program was used in the analysis of the 7 genome-wide association studies carried out by the Wellcome Trust Case-Control Consortium (WTCCC). (entry from Genetic Analysis Software)

View all literature mentions

IMPUTE2 (tool)

RRID:SCR_013055

A computer program for phasing observed genotypes and imputing missing genotypes.

View all literature mentions